@vialase

Yes, it's Real.

ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation
ViaLase | Redefining Glaucoma Treatment
ViaLase | Redefining Glaucoma Treatment
Registration | Eyecelerator @ AAO 2024
Registration | Eyecelerator @ AAO 2024
Take FLIGHT With the ViaLuxe™ Laser System
Take FLIGHT With the ViaLuxe™ Laser System
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser
Laser Focus - Sitting Down With Tibor Juhasz, femtosecond laser pioneer and CEO of ViaLase
Laser Focus - Sitting Down With Tibor Juhasz, femtosecond laser pioneer and CEO of ViaLase
ViaLase at Octane's Ophthalmology Tech Forum
Time to Take FLigHT?
Time to Take FLigHT?
Noninvasive Trabeculotomy Treatment for Glaucoma - Glaucoma Today
Noninvasive Trabeculotomy Treatment for Glaucoma - Glaucoma Today
Durable 36 Month IOP Reduction in Open Angle Glaucoma with Femtosecond Laser Guided High Precision Trabeculotomy (FLigHT)
ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
Glaucoma Physician - The Latest in Laser Treatment for Glaucoma
Glaucoma Physician - The Latest in Laser Treatment for Glaucoma
Seeing is Believing | ViaLase

View on mobile